| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.5M | -56.0% |
| SG&A Expense | $11.5M | -55.2% |
| Operating Income | -$23.0M | +55.6% |
| Pre-tax Income | -$21.8M | +51.0% |
| Income Tax | $66K | +0.0% |
| Net Income | -$21.8M | +51.1% |
| EPS (Basic) | -$8.35 | -584.4% |
| EPS (Diluted) | -$8.35 | -496.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -43.3% |
| Current Assets | $14.0M | -42.1% |
| Total Assets | $15.0M | -41.2% |
| Current Liabilities | $4.7M | -49.4% |
| Total Liabilities | $5.1M | -48.4% |
| Stockholders' Equity | $8.5M | -40.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.1M | +51.4% |
| Capital Expenditures | $6K | -94.4% |
| Investing Cash Flow | -$6K | +94.4% |
| Financing Cash Flow | $13.0M | -78.8% |
| Free Cash Flow | -$23.1M | +51.5% |